LEADER

In Innovation

BOARD OF DIRECTORS

William T. Abraham,
MD, FACP, FACC, FAHA, FESC, FRCPE
Professor of Medicine, Physiology, & Cell Biology
College of Medicine Distinguished Professor
Division of Cardiovascular Medicine
The Ohio State University

B. Kristine Johnson
General Partner
Affinity Capital Management

Kirk Nielsen
Managing Director
Versant Ventures

Jonathan A. Rennert
Chief Executive Officer
ZOLL Medical Corporation

Zach Scott
Managing Partner
Revelation Partners

Peter Sommerness
President and CEO
Respicardia®, Inc.

Thomas D. Weldon
Chairman and Managing Director
Accuitive Medical Ventures

Am I a candidate
for remedē®?
CLOSE

For Patients

IMPORTANT SAFETY INFORMATION

The remedē® System is indicated for moderate to severe Central Sleep Apnea in adult patients.

Your doctor will need to evaluate your condition to determine if the remedē system is right for you. You will not be able to have an MRI or diathermy (special heat therapies) if you have the remedē system implanted. The remedē system may be used if you have another stimulation device such as a heart pacemaker or defibrillator; special testing will be needed to ensure the devices are not interacting.

As with any surgically implanted device, there are risks related to the surgical procedure itself which may include, but are not limited to, pain, swelling, and infection.

Once the therapy is turned on, some patients may experience discomfort from stimulation and/or from the presence of the device. The majority of these events are resolved either on their own or by adjusting the therapy settings. The remedē system may not work for everyone. There are additional risks associated with removing your system. If you and your doctor decide to remove the system, another surgery will be required.

Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the remedē system. Rx only. For further information, please call +1-952-540-4470 or email info@respicardia.com.